- Disease: Respiratory syncytial virus infection
- Study type: Observational Cohort Study, Natural History
- Study type descriptors: Prospective, Multicentre
- Objective: To assess the seroprevalence and incidence of RSV disease during the study period in the targeted countries and sites for a Phase III vaccine study
- Number of participants enrolled: 1000
- Study enrolling from to
- Study includes follow-up for 6 months
Study Data
- General population
- Infants (<1 year)
- Children (1-11 years)
- Primary care
- Respiratory syncytial virus
- Respiratory syncytial virus infection
External Links
Other information
Funders/Sponsors:
- Sanofi Pasteur
If you would like to contact the Principal Investigator of the study please email: ccb@ateneo.univr.it
The data is updated up to